ClinicalTrials.gg
RecruitingNCT02663388OBESEPIUpdated Oct 27, 2016

Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)

An observational study in Obesity, Diabetes and Metabolic Diseases, sponsored by University of Lorraine. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-10-27.

Sponsored by University of Lorraine · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20,000
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 476 studies in Obesity with a site in France — 112 open to participants now, 128 under way, 25 of them phase 3. Obesity · France.

Planned enrollment
Largest of 121
20,000 · median 133
Started
2016
with 22 others
Observational
121 of 476
27 open now
Primary completion
2026-01
later than 22 of 127 live
Registered
168th of 476
by date

Among the 476 studies in Obesity with a site in France, this one has the largest planned enrollment of the 121 observational ones that give a count, is one of 23 that started in 2016, is one of 121 observational ones, reaches primary completion later than 22 of the 127 other live ones, and was the 168th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

112 of the 476 studies in Obesity with a site in France are open now. Recruiting first, the newest first:

107 more — sign in →

All 112 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 476 studies in Obesity with a site in France, or all of them as a file.
02

Study summary

The purpose of this study was to evaluate the role of vitamin status and epigenetic mechanisms on severe obesity related-complications.

03

Conditions studied

  • Obesity
  • Diabetes
  • Metabolic Diseases
  • Non-alcoholic Fatty Liver Disease
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who undergo bariatric surgery following french national guidelines (HAS 2009)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • indication for bariatric surgery with > 35 kg/m2

Exclusion criteria

Exclusion Criteria:

  • unable to receive clear information
  • refusal to sign the consent form
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20,000 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes
Biospecimen retention
Samples with dna

Interventions

  • Proceduregastric bypass, sleeve, gastric banding
06

What researchers measure

Primary outcomes

  1. Evaluation of folate mediated one-carbon metabolic pathway parameters (Folates, Vitamin B12, Methionine, Homocysteine) on severe obesity-related complications before and after bariatric surgery

    Time frame: 10 years

Secondary outcomes

  1. Evaluation of DNA Methylation on severe obesity-related complications before and after bariatric surgery

    Time frame: 10 years

07

Study locations

1 of 1 sites recruiting
  • University of Lorraine, CHU Nancy
    Vandoeuvre Les Nancy, 54511, France
    Recruiting
08

References and documents

Publications

  • Antoine D, Li Z, Quilliot D, Sirveaux MA, Meyre D, Mangeon A, Brunaud L, Gueant JL, Gueant-Rodriguez RM. Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery. Clin Nutr. 2021 Jan;40(1):87-93. doi: 10.1016/j.clnu.2020.04.029. Epub 2020 Apr 25. PubMed 32444241 ↗
  • Li Z, Gueant-Rodriguez RM, Quilliot D, Sirveaux MA, Meyre D, Gueant JL, Brunaud L. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity. Clin Nutr. 2018 Oct;37(5):1700-1706. doi: 10.1016/j.clnu.2017.07.008. Epub 2017 Jul 24. PubMed 28780990 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2016, a primary completion of Jan 2026 and a completion of Jan 2026. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 11, 2016
First posted
Jan 26, 2016
Start
Jan 2016
Primary completionEst.
Jan 2026
CompletionEst.
Jan 2026
Last update
Oct 27, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 27, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02663388
Lead sponsor
University of Lorraine
Responsible party
Laurent Brunaud (Pr Laurent BRUNAUD, MD, PhD, University of Lorraine) — Principal investigator
First posted
Jan 26, 2016
Start date
Jan 2016
Primary completion
Jan 2026 (estimated)
Completion
Jan 2026 (estimated)
Last update
Oct 27, 2016

Study contacts

Laurent BRUNAUD, MD, PhD
Contact
l.brunaud@chu-nancy.fr
laurent BRUNAUD, MD, PhD
principal investigator · University of Lorraine, CHU Nancy
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion